What is the current valuation of the India brucellosis market in 2024?

The overall market valuation was $49.32 Million in 2024. Read More

What is the projected market valuation for the India brucellosis market by 2035?

The projected valuation for 2035 is $103.5 Million. Read More

What is the expected CAGR for the India brucellosis market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 6.97%. Read More

Which companies are the key players in the India brucellosis market?

Key players include Zoetis, Merck & Co., Boehringer Ingelheim, Ceva Santé Animale, Heska Corporation, Virbac, Vetoquinol, and Phibro Animal Health Corporation. Read More

What are the main species segments in the India brucellosis market and their valuations?

The species segments include Brucella abortus ($15.0 - $30.0 Million), Brucella melitensis ($10.0 - $20.0 Million), and others. Read More

What diagnostic methods are utilized in the India brucellosis market?

Diagnostic methods include serological tests ($5.0 - $10.0 Million) and molecular techniques ($8.0 - $15.0 Million), among others. Read More

What treatment options are available in the India brucellosis market?

Treatment options include antibiotics ($20.0 - $42.0 Million) and vaccines ($15.0 - $30.0 Million). Read More

Who are the primary end-users in the India brucellosis market?

Primary end-users include hospitals & diagnostic centers ($20.0 - $42.0 Million) and pharmaceutical & biotechnology companies ($15.0 - $30.0 Million). Read More

How does the market for Brucella canis compare to other species in terms of valuation?

The market for Brucella canis is valued between $7.0 - $15.0 Million, which is lower than Brucella abortus and Brucella melitensis. Read More

What trends are anticipated in the India brucellosis market as it approaches 2035?

Trends may indicate growth driven by advancements in diagnostics and treatment, alongside increasing awareness of brucellosis. Read More

India Brucellosis Market

ID: MRFR/LS/51835-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

India Brucellosis Market Research Report: Size, Share, Trend Analysis By Species (Brucella suis, Brucella abortus, Brucella melitensis, Brucella canis, others), By End-User (hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies, others), By Diagnosis (serological tests, molecular techniques, bone marrow biopsy, X-rays, computerized tomography (CT), magnetic resonance imaging (MRI), cerebrospinal fluid culture, echocardiography, others), By Treatment (antibiotics, vaccines, others), By Region – Forecast to 2035

India Brucellosis Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.28%

2024 Market Size$ 32.88 Million

2025 Market Size$ 35.53 Million

2035 Market Size$ 64.25 Million

Key Players

Indian Immunologicals Limited

Bharat Biotech International Limited

Hester Biosciences Limited

Zoetis India Limited

Merck Animal Health

Vetoquinol India Animal Health Private Limited

Trends

Rising Awareness of Zoonotic Diseases
Government Initiatives for Livestock Health
Advancements in Diagnostic Technologies

Opportunities

Growing Public Health Concerns
Increasing Livestock Population
Government Regulations and Policies

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Species (USD Million)
  1. 4.1.1 Brucella suis
  2. 4.1.2 Brucella abortus
  3. 4.1.3 Brucella melitensis
  4. 4.1.4 Brucella canis
  5. 4.1.5 others
2. 4.2 Industrial Automation & Equipment, BY Diagnosis (USD Million)
  1. 4.2.1 serological tests
  2. 4.2.2 molecular techniques
  3. 4.2.3 bone marrow biopsy
  4. 4.2.4 X-rays
  5. 4.2.5 computerized tomography (CT)
  6. 4.2.6 magnetic resonance imaging (MRI)
  7. 4.2.7 cerebrospinal fluid culture
  8. 4.2.8 echocardiography
  9. 4.2.9 others
3. 4.3 Industrial Automation & Equipment, BY Treatment (USD Million)
  1. 4.3.1 antibiotics
  2. 4.3.2 vaccines
  3. 4.3.3 others
4. 4.4 Industrial Automation & Equipment, BY End-User (USD Million)
  1. 4.4.1 hospitals & diagnostic centers
  2. 4.4.2 academic institutes
  3. 4.4.3 pharmaceutical & biotechnology companies
  4. 4.4.4 others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Zoetis (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck & Co. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Ceva Santé Animale (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Heska Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Virbac (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Vetoquinol (FR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Phibro Animal Health Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY SPECIES
3. 6.3 INDIA MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 INDIA MARKET ANALYSIS BY TREATMENT
5. 6.5 INDIA MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SPECIES, 2024 (% SHARE)
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SPECIES, 2024 TO 2035 (USD Million)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS, 2024 (% SHARE)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 (% SHARE)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USER, 2024 (% SHARE)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SPECIES, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Species (USD Million, 2025-2035)

Brucella suis
Brucella abortus
Brucella melitensis
Brucella canis
others

Industrial Automation & Equipment By Diagnosis (USD Million, 2025-2035)

serological tests
molecular techniques
bone marrow biopsy
X-rays
computerized tomography (CT)
magnetic resonance imaging (MRI)
cerebrospinal fluid culture
echocardiography
others

Industrial Automation & Equipment By Treatment (USD Million, 2025-2035)

antibiotics
vaccines
others

Industrial Automation & Equipment By End-User (USD Million, 2025-2035)

hospitals & diagnostic centers
academic institutes
pharmaceutical & biotechnology companies
others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”